Globeflex Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-13
Closed -$2K 559
2020
Q1
$2K Hold
13
﹤0.01% 479
2019
Q4
$2K Hold
13
﹤0.01% 486
2019
Q3
$1K Hold
13
﹤0.01% 501
2019
Q2
$1K Buy
+13
New +$1.53K ﹤0.01% 502
2014
Q3
Sell
-55
Closed -$3K 612
2014
Q2
$3K Sell
55
-4
-7% -$239 ﹤0.01% 424
2014
Q1
$3K Hold
59
﹤0.01% 404
2013
Q4
$3K Buy
59
+28
+90% +$1.4K ﹤0.01% 409
2013
Q3
$1K Hold
31
﹤0.01% 509
2013
Q2
$1K Buy
+31
New +$1.69K ﹤0.01% 507

Other funds holding LLY

Globeflex Capital's LLY Position: Q2 2020 in Review

Globeflex Capital sold out of Eli Lilly (LLY) in Q2 2020, closing a stake of 13 shares — an estimated $2K sold.

Globeflex Capital first reported a position in LLY in Q2 2013 and held it in 9 quarters. The position peaked at $3K in Q2 2014. 1,764 funds tracked by Wall St. Rank hold LLY as of Q2 2020.

  • Globeflex Capital reported no remaining Eli Lilly position as of Q2 2020 after selling out during the quarter.
  • Globeflex Capital sold 13 Eli Lilly shares in Q2 2020, an estimated $2K.
  • Globeflex Capital first reported a position in Eli Lilly in Q2 2013 and held it in 9 quarters.
  • Globeflex Capital's Eli Lilly position peaked at $3K in Q2 2014.
  • 1,764 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2020.

Based on Globeflex Capital's 13F filing for Q2 2020, filed 12 Aug 2020.